Read more
April 2023
Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April…
Read more
April 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…
Read more
March 2023
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
Read more
March 2023
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…
January 2023
BHF-funded researchers are paving the way towards future breakthroughs in heart disease research. Here are 5 big questions we’re helping…
Read more
January 2022
Cardiovascular disease is the world’s biggest killer, responsible for almost 18m deaths a year, according to the World Health Organization….
Read more
December 2021
From AI technology that can predict heart attacks to a potential new drug for incurable vascular dementia, the BHF has…
Read more
December 2021
Oxford is already home to one of the world’s most prestigious universities. Now its startup scene is finally getting the…
Get in touch for more information.
